Literature DB >> 23443958

Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.

Marijn M Speeckaert1, Reinhart Speeckaert, Juan J Carrero, Raymond Vanholder, Joris R Delanghe.   

Abstract

The pentraxin superfamily consists of highly conserved multimeric pattern recognition proteins, which are components of the humoral arm of innate immunity. Besides the classical pentraxins (C-reactive protein and serum amyloid P component), pentraxin 3 (PTX3) is a prototypic long pentraxin. In response to primary inflammatory signals, this multifunctional acute phase protein is produced by a variety of cell types. Recently, several clinical studies have demonstrated that PTX3 is significantly associated with kidney dysfunction and disease activity or severity in various inflammatory, cardiovascular and autoimmune diseases. In this paper, we will review the general characteristics of PTX3 focusing in particular on its fundamental biological functions in the course of acute and chronic kidney diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23443958     DOI: 10.1007/s10875-013-9879-0

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  100 in total

1.  Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.

Authors:  Ruth Dubin; Yongmei Li; Joachim H Ix; Michael G Shlipak; Mary Whooley; Carmen A Peralta
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

2.  M-ficolin interacts with the long pentraxin PTX3: a novel case of cross-talk between soluble pattern-recognition molecules.

Authors:  Evelyne Gout; Christine Moriscot; Andrea Doni; Chantal Dumestre-Pérard; Monique Lacroix; Julien Pérard; Guy Schoehn; Alberto Mantovani; Gérard J Arlaud; Nicole M Thielens
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

3.  Detection of anti-PTX3 autoantibodies in systemic lupus erythematosus.

Authors:  Jean-François Augusto; Céline Onno; Simon Blanchard; Sylvain Dubuquoi; Alberto Mantovani; Alain Chevailler; Pascale Jeannin; Jean-François Subra
Journal:  Rheumatology (Oxford)       Date:  2009-02-12       Impact factor: 7.580

4.  Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation.

Authors:  Mahmut Ilker Yilmaz; Juan Jesús Carrero; Jose Luis Martín-Ventura; Alper Sonmez; Mutlu Saglam; Turgay Celik; Halil Yaman; Mujdat Yenicesu; Tayfun Eyileten; Juan Antonio Moreno; Jesús Egido; Luis Miguel Blanco-Colio
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-29       Impact factor: 8.237

5.  Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors.

Authors:  Daria Leali; Patrizia Alessi; Daniela Coltrini; Roberto Ronca; Michela Corsini; Giorgia Nardo; Stefano Indraccolo; Marco Presta
Journal:  Mol Cancer Ther       Date:  2011-07-15       Impact factor: 6.261

6.  Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease.

Authors:  Tetsu Miyamoto; Abdul Rashid Qureshi; Olof Heimbürger; Peter Bárány; Karin Carrero; Bodil Sjöberg; Bengt Lindholm; Peter Stenvinkel; Juan Jesús Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

7.  Activation of the lectin complement pathway in Henoch-Schönlein purpura nephritis.

Authors:  Satoshi Hisano; Misao Matsushita; Teizo Fujita; Hiroshi Iwasaki
Journal:  Am J Kidney Dis       Date:  2005-02       Impact factor: 8.860

8.  Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality.

Authors:  Mengli Tong; Juan Jesús Carrero; A Rashid Qureshi; Björn Anderstam; Olof Heimbürger; Peter Bárány; Jonas Axelsson; Anders Alvestrand; Peter Stenvinkel; Bengt Lindholm; Mohamed E Suliman
Journal:  Clin J Am Soc Nephrol       Date:  2007-08-16       Impact factor: 8.237

9.  A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients.

Authors:  Betti Giusti; Gabriella Fibbi; Francesca Margheri; Simona Serratì; Luciana Rossi; Filippo Poggi; Ilaria Lapini; Alberto Magi; Angela Del Rosso; Marina Cinelli; Serena Guiducci; Bashar Kahaleh; Laura Bazzichi; Stefano Bombardieri; Marco Matucci-Cerinic; Gian Franco Gensini; Mario Del Rosso; Rosanna Abbate
Journal:  Arthritis Res Ther       Date:  2006-07-19       Impact factor: 5.156

10.  The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.

Authors:  Viviana P Ferreira; Andrew P Herbert; Claudio Cortés; Kristi A McKee; Bärbel S Blaum; Stefan T Esswein; Dusan Uhrín; Paul N Barlow; Michael K Pangburn; David Kavanagh
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

View more
  12 in total

1.  Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study.

Authors:  Ran Lee; Min-Ho Shin; Hee-Nam Kim; Young-Hoon Lee; Seong-Woo Choi; Hye-Ran Ahn; Sun-Seog Kweon
Journal:  Int Urol Nephrol       Date:  2017-07-21       Impact factor: 2.370

2.  PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis.

Authors:  Nicola Bassi; Dorella Del Prete; Anna Ghirardello; Mariele Gatto; Monica Ceol; Margherita Zen; Silvano Bettio; Alberto Mantovani; Luca Iaccarino; Leonardo Punzi; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

3.  Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease.

Authors:  Naoki Nakagawa; Luke Barron; Ivan G Gomez; Bryce G Johnson; Allie M Roach; Sei Kameoka; Richard M Jack; Mark L Lupher; Sina A Gharib; Jeremy S Duffield
Journal:  JCI Insight       Date:  2016-12-08

4.  Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis.

Authors:  Susana Rocha; Maria João Valente; Susana Coimbra; Cristina Catarino; Petronila Rocha-Pereira; José Gerardo Oliveira; José Madureira; João Carlos Fernandes; Maria do Sameiro-Faria; Vasco Miranda; Luís Belo; Alice Santos-Silva; Elsa Bronze-da-Rocha
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

5.  Relationship between Sustained Reductions in Plasma Lipid and Lipoprotein Concentrations with Apheresis and Plasma Levels and mRNA Expression of PTX3 and Plasma Levels of hsCRP in Patients with HyperLp(a)lipoproteinemia.

Authors:  Claudia Stefanutti; Fabio Mazza; Michael Steiner; Gerald F Watts; Joel De Nève; Daniela Pasqualetti; Juergen Paal
Journal:  Mediators Inflamm       Date:  2016-01-19       Impact factor: 4.711

Review 6.  Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease.

Authors:  Simona Granata; Alessandra Dalla Gassa; Gloria Bellin; Antonio Lupo; Gianluigi Zaza
Journal:  Biomed Res Int       Date:  2016-06-21       Impact factor: 3.411

Review 7.  Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.

Authors:  Raymond Vanholder; Anneleen Pletinck; Eva Schepers; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2018-01-08       Impact factor: 4.546

8.  Exogenous pentraxin-3 inhibits the reactive oxygen species-mitochondrial and apoptosis pathway in acute kidney injury.

Authors:  Hyung Ho Lee; Sook Young Kim; Joon Chae Na; Young Eun Yoon; Woong Kyu Han
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

9.  Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies.

Authors:  Eszter Trojnar; Mihály Józsi; Zsóka Szabó; Marienn Réti; Péter Farkas; Kata Kelen; George S Reusz; Attila J Szabó; Nóra Garam; Bálint Mikes; György Sinkovits; Blanka Mező; Dorottya Csuka; Zoltán Prohászka
Journal:  Front Immunol       Date:  2019-02-25       Impact factor: 7.561

10.  Study on Association of Pentraxin 3 and Diabetic Nephropathy in a Rat Model.

Authors:  Xuehai Chen; Jiao Luo; Minmin Wu; Zhuo Pan; Yue Xie; Hongwei Wang; Bicheng Chen; Hong Zhu
Journal:  J Diabetes Res       Date:  2018-03-13       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.